Agilent Technologies Inc. recently announced new solutions for the cannabis and hemp testing markets.
Agilent Technologies Inc. recently announced new solutions for the cannabis and hemp testing markets. The Agilent eMethods product, Cannabis and Hemp Potency Kit, and Cannabis Pesticide and Mycotoxin Kit help testing laboratories create easy and effective solutions to get them running quickly.
In the company’s press release (1) they stated that “developing reliable testing protocols for complex matrices such as cannabis and hemp is arduous and time-consuming, especially for newer laboratories.” The Agilent eMethods product reportedly administers downloadable ready-to-run instrumental methods with an end-to-end workflow that addresses different testing needs and also offers guidance on sample preparation, consumables, and supplies. Aside from those benefits, the program also yields a complete analytical system configuration for automation, sample introduction, separation, detection, and is enabled with data processing and reporting capabilities.
“The fledgling market of cannabis and hemp testing has an urgent need for solutions that help ensure efficiency as well as regulatory compliance,” said Monty Benefiel, Agilent Vice President, and General Manager of the Mass Spectrometry Division (1). “Our new tool—Agilent eMethods—along with the Cannabis and Hemp Potency Kit and Cannabis Pesticide and Mycotoxin Kit gives labs a head start in establishing testing procedures, increasing productivity and profitability, and greatly reducing risk.”
Agilent’s new solutions support laboratories by providing fast setup and simplification of the analysis of the complex matrices that are involved with cannabis and hemp testing. Beginning with sample preparation all the way through to testing, these kits will reportedly allow laboratories to better navigate diverse regulations, which helps them stay up-to-date and compliant.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.